[1] LI X, SONG P, LI J, et al. The Disease Burden and Clinical Characteristics of Inflammatory Bowel Disease in the Chinese Population: A Systematic Review and Meta-Analysis. Int J Environ Res Public Health. 2017;14(3):238.
[2] YANG H, LI Y, WU W, et al. The incidence of inflammatory bowel disease in Northern China: a prospective population-based study. PLoS One. 2014; 9(7):e101296.
[3] ROGLER G. Chronic ulcerative colitis and colorectal cancer. Cancer Lett. 2014;345(2):235-241.
[4] 王晓蕾,欧阳春晖,高翔,等.溃疡性结肠炎降阶梯治疗对象的选择[J].中华炎性肠病杂志,2020,4(1):67-70.
[5] GEARRY RB, BARCLAY ML. Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease. J Gastroenterol Hepatol. 2005;20(8):1149-1157.
[6] PANÉS J, GARCÍA-OLMO D, VAN ASSCHE G, et al. Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn’s disease: a phase 3 randomised, double-blind controlled trial. Lancet. 2016;388(10051):1281-1290.
[7] HORWITZ EM, LE BLANC K, DOMINICI M, et al. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy. 2005;7(5):393-395.
[8] UDER C, BRÜCKNER S, WINKLER S, et al. Mammalian MSC from selected species: Features and applications. Cytometry A. 2018;93(1):32-49.
[9] YU YB, SONG Y, CHEN Y, et al. Differentiation of umbilical cord mesenchymal stem cells into hepatocytes in comparison with bone marrow mesenchymal stem cells. Mol Med Rep. 2018;18(2):2009-2016.
[10] 刘美辰,刘霞,肖苒,等.脂肪间充质干细胞治疗皮肤老化的研究进展[J].组织工程与重建外科杂志,2014,10(4):236-239.
[11] ROMANOV YA, VOLGINA NE, VTORUSHINA VV, et al. Comparative Analysis of Secretome of Human Umbilical Cord- and Bone Marrow-Derived Multipotent Mesenchymal Stromal Cells. Bull Exp Biol Med. 2019;166(4): 535-540.
[12] 何小文,陈泽贤,张珑涓,等.骨髓间充质干细胞移植治疗炎症性肠病小鼠结肠炎的有效性及肿瘤学安全性[J].中国组织工程研究,2014, 18(23):3696-3701.
[13] HU J, ZHAO G, ZHANG L, et al. Safety and therapeutic effect of mesenchymal stem cell infusion on moderate to severe ulcerative colitis. Exp Ther Med. 2016;12(5):2983-2989.
[14] KNYAZEV OV, PARFENOV AI, KONOPLYANNIKOV AG, et al. Safety of mesenchymal stromal cell therapy for inflammatory bowel diseases: results of a 5-year follow-up. Ter Arkh. 2015;87(2):39-44.
[15] SHI X, CHEN Q, WANG F. Mesenchymal stem cells for the treatment of ulcerative colitis: a systematic review and meta-analysis of experimental and clinical studies. Stem Cell Res Ther. 2019;10(1):266.
[16] LIANG J, ZHANG H, WANG D, et al. Allogeneic mesenchymal stem cell transplantation in seven patients with refractory inflammatory bowel disease. Gut. 2012;61(3):468-469.
[17] LAZEBNIK LB, KONOPLIANNIKOV AG, KNIAZEV OV, et al. Use of allogeneic mesenchymal stem cells in the treatment of intestinal inflammatory diseases. Ter Arkh. 2010;82(2):38-43.
[18] LAZEBNIK LB, KNIAZEV OV, KONOPLIANNIKOV AG, et al. Allogeneic mesenchymal stromal cells in patients with ulcerative colitis: two years of observation. Eksp Klin Gastroenterol. 2010;(11):3-15.
[19] KNYAZEV O, KAGRAMANOVA A, FADEEVA N, et al. Relative frequency of relapses in patients with ulcerative colitis and Crohn’s disease treated with mesenchymal stromal cells-5 years of follow-up. United European Gastroenterol J. 2017;5(5):A291.
[20] 杨波,赵振林,樊强.自体骨髓间充质干细胞治疗溃疡性结肠炎疗效分析[J].临床医药实践,2015,24(7):493-497.
[21] KNYAZEV OV, PARFENOV AI, KONOPLYANNIKOV AG, et al. Use of mesenchymal stem cells in the combination therapy of ulcerative colitis. Ter Arkh. 2016;88(2):44-48.
[22] 熊轩轩,吴克俭,费素娟,等.骨髓间充质干细胞治疗大鼠溃疡性结肠炎的作用及机制研究[J]. 中华临床医师杂志(电子版),2013,7(7):3029-3035.
[23] ROBINSON AM, RAHMAN AA, MILLER S, et al. The neuroprotective effects of human bone marrow mesenchymal stem cells are dose-dependent in TNBS colitis. Stem Cell Res Ther. 2017;8(1):87.
[24] GONÇALVES FDA C, SCHNEIDER N, PINTO FO, et al. Intravenous vs intraperitoneal mesenchymal stem cells administration: what is the best route for treating experimental colitis? World J Gastroenterol. 2014;20(48): 18228-18239.
[25] 葛翠翠.人脐带间充质干细胞对炎症性肠病小鼠模型的治疗作用及移植相关问题探讨[D].合肥:安徽医科大学,2013.
[26] WANG M, LIANG C, HU H, et al. Intraperitoneal injection (IP), Intravenous injection (IV) or anal injection (AI)? Best way for mesenchymal stem cells transplantation for colitis. Sci Rep. 2016;6:30696.
[27] PAN XH, LI QQ, ZHU XQ, et al. Mechanism and therapeutic effect of umbilical cord mesenchymal stem cells in inflammatory bowel disease. Sci Rep. 2019;9(1):17646.
[28] 林艳,郑长青.干细胞移植治疗炎症性肠病:造血干细胞和间充质干细胞的应用[J].华西医学,2015,30(3):565-568.
[29] 段征,徐艳华,陈小云,等.间充质干细胞移植后在溃疡性结肠炎大鼠体内的迁移[J].重庆医科大学学报,2010,35(8):1152-1155.
[30] 翟俊山,李方,孙亚梅,等.人脐带间充质干细胞对小鼠实验性溃疡性结肠炎的疗效[J].中华细胞与干细胞杂志(电子版),2017,7(2):87-92.
[31] BRITTAN M, HUNT T, JEFFERY R, et al. Bone marrow derivation of pericryptal myofibroblasts in the mouse and human small intestine and colon. Gut. 2002;50(6):752-757.
[32] TOLSTANOVA G, KHOMENKO T, DENG X, et al. New molecular mechanisms of the unexpectedly complex role of VEGF in ulcerative colitis. Biochem Biophys Res Commun. 2010;399(4):613-616.
[33] DENG X, SZABO S, CHEN L, et al. New cell therapy using bone marrow-derived stem cells/endothelial progenitor cells to accelerate neovascularization in healing of experimental ulcerative colitis. Curr Pharm Des. 2011;17(16):1643-1651.
[34] HAYASHI Y, TSUJI S, TSUJII M, et al. Topical implantation of mesenchymal stem cells has beneficial effects on healing of experimental colitis in rats. J Pharmacol Exp Ther. 2008;326(2):523-531.
[35] 张夏梦,寿折星,石月萍,等.骨髓间充质干细胞对溃疡性结肠炎大鼠结肠组织血管内皮的修复作用[J].世界华人消化杂志,2013,21(28):2908-2914.
[36] GIRDLESTONE J. Mesenchymal stromal cells with enhanced therapeutic properties. Immunotherapy. 2016;8(12):1405-1416.
[37] CHRISTOPHI GP, RONG R, HOLTZAPPLE PG, et al. Immune markers and differential signaling networks in ulcerative colitis and Crohn’s disease. Inflamm Bowel Dis. 2012;18(12):2342-2356.
[38] ZHANG F, MENG G, STROBER W. Interactions among the transcription factors Runx1, RORgammat and Foxp3 regulate the differentiation of interleukin 17-producing T cells. Nat Immunol. 2008;9(11):1297-1306.
[39] XU AT, LU JT, RAN ZH, et al. Exosome in intestinal mucosal immunity. Journal of Gastroenterology and Hepatology. 2016;31(10):1694-1699.
[40] 刘与进,范恒,刘星星.炎症性肠病与干细胞源性微囊泡的研究进展[J].华中科技大学学报(医学版),2017,46(6):709-714.
[41] 朱立伟,朱达坚.外泌体在炎症性肠病中的研究进展[J].广东医科大学学报,2018,36(6):609-612.
[42] 张丹,肖凤军,聂文博,等.间充质干细胞治疗溃疡性结肠炎的研究现状与展望[J].军事医学,2019,43(10):797-801.
|